AUTL - CIK 0001730463
The table below shows Autolus Therapeutics plc's balance sheet by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
| Line item | Q1 2026 | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $130.93M | $86.12M | $123.83M | $95.80M | $657.07M | $705.94M |
| Short-term investments | - | - | - | - | - | - |
| Receivables | $27.66M | - | - | - | $0.00 | $0.00 |
| Inventory | $33.23M | $27.72M | $23.94M | $14.65M | - | - |
| Total current assets |
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| $368.83M |
| $514.58M |
| $574.25M |
| $615.77M |
| $718.11M |
| $758.60M |
| Property, plant & equipment | $61.91M | $66.85M | $66.47M | $57.97M | $44.26M | $32.86M |
| Goodwill | - | - | - | - | - | - |
| Total assets | $527.07M | $661.95M | $720.98M | $746.34M | $827.49M | $853.62M |
| Accounts payable | $1.87M | $10.97M | $5.41M | $4.46M | $1.42M | $1.10M |
| Total current liabilities | $63.60M | $83.07M | $68.15M | $66.61M | $52.47M | $40.90M |
| Long-term debt | - | - | - | - | - | - |
| Total liabilities | $418.24M | $396.50M | $374.52M | $375.23M | $350.52M | $325.78M |
| Retained earnings | -$1.46B | -$1.30B | -$1.22B | -$1.17B | -$1.07B | -$989.52M |
| Total equity | $108.83M | $265.45M | $346.46M | $371.11M | $476.96M | $527.84M |